Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.31 |
| ▸ | PPARG | P37231 | 7/20 | 0.31 |
| ▸ | PPARD | Q03181 | 7/20 | 0.31 |
| ▸ | PPARA | Q07869 | 7/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.31 |
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | TLR2 | O60603 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | FABP4 | P15090 | 2/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17167185 | 0.78 | FFAR3 (0.37) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8986187 | 0.77 | ALDH1A1 (0.34) | ALDH1A1EGLN1 | |
| SCHEMBL27523 | 0.75 | — | — | |
| SCHEMBL8665800 | 0.75 | ALDH1A1 (0.48) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL18349784 | 0.75 | THRB (0.50) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8845942 | 0.74 | AKR1B1 (0.42) | PLA2G4BALDH1A1AKR1B1GPR84PPARG | |
| SCHEMBL27820166 | 0.74 | EGLN1 (0.36) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8932043 | 0.74 | ALDH1A1 (0.37) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL439265 | 0.74 | ALDH1A1 (0.37) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL9883735 | 0.74 | ALDH1A1 (0.37) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022234-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | BOUSQUET-GAGNON NATHALIE (CA) | 2012-01-26 | — | — | US | disclosed |
| EP-2230257-A1 | Method for the purification of albumin conjugates | ConjuChem Biotechnologies Inc. (CA) | 2010-09-22 | — | — | EP | disclosed |
| EP-2100904-B1 | Solid phase for use in a method for the purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2010-07-07 | — | — | EP | disclosed |
| EP-2100904-A1 | Solid phase for use in a method for the purification of albumin conjugates | ConjuChem Biotechnologies Inc. (CA) | 2009-09-16 | — | — | EP | disclosed |
| EP-1745078-B1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2009-06-17 | — | — | EP | disclosed |
| US-20080146783-A1 | Method for the purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. | 2008-06-19 | — | — | US | disclosed |
| US-7307148-B2 | Method for purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-12-11 | — | — | US | disclosed |
| EP-1745078-A4 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2007-08-01 | — | — | EP | disclosed |
| EP-1745078-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | ConjuChem Biotechnologies Inc. (CA) | 2007-01-24 | — | — | EP | disclosed |
| US-20050267293-A1 | Method for purification of albumin conjugates | CONJUCHEM, INC. (CA) | 2005-12-01 | — | — | US | disclosed |
| WO-2005103087-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022234-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | ALB, DNPEP, SLC7A1 | FFAR3 2696/4885HDAC3 3181/4885HDAC1 3082/4885 |
| US-20050267293-A1 | Method for purification of albumin conjugates | ALB, DNPEP, SLC7A1 | FFAR3 2973/4885HDAC3 3478/4885HDAC1 3225/4885 |
| US-20080146783-A1 | Method for the purification of albumin conjugates | ALB, DNPEP, SLC7A1 | FFAR3 2696/4885HDAC3 3181/4885HDAC1 3082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.